Scott Waldman, Thomas Jefferson University (IMAGE)

Thomas Jefferson University

Scott Waldman, Thomas Jefferson University

Caption

Scott Waldman, M.D., Ph.D., chair of the Department of Pharmacology and Experimental Therapeutics at Jefferson and director of the Gastrointestinal Cancer Program at Jefferson's Kimmel Cancer Center, and colleagues found that silencing hormone receptor weakens intestinal barrier, making body more susceptible to cancer

Credit

TJUH

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.